Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of Cyclosporine Ophthalmic Emulsion 0.05%
(RESTASIS®) in patients with primary pterygium (abnormal growth on surface of eye).